RBFOX3/NeuN Protein

RBFOX3/NeuN Protein

RBFOX3, most widely known as NeuN (Neuronal Nuclear Protein), is a neuron-specific RNA-binding protein that serves as one of the most commonly used markers for identifying neurons in histological studies. This protein was first identified in 1992 when monoclonal antibodies raised against mouse brain tissue revealed a nuclear antigen specifically expressed in post-mitotic neurons. Over the decades, RBFOX3 has evolved from a simple histological marker to a protein of significant biological and clinical importance, with research establishing it as a member of the RBFOX family of RNA-binding proteins involved in alternative splicing regulation. Unlike RBFOX1 and RBFOX2, which are expressed in both neuronal and non-neuronal tissues, RBFOX3/NeuN expression is restricted to neurons in the central and peripheral nervous systems, making it uniquely important for neuronal gene expression regulation [@liu2012].

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RBFOX3/NeuN Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RBFOX3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RBFOX3/NeuN</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=RBFOX3" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

RBFOX3/NeuN Protein

RBFOX3, most widely known as NeuN (Neuronal Nuclear Protein), is a neuron-specific RNA-binding protein that serves as one of the most commonly used markers for identifying neurons in histological studies. This protein was first identified in 1992 when monoclonal antibodies raised against mouse brain tissue revealed a nuclear antigen specifically expressed in post-mitotic neurons. Over the decades, RBFOX3 has evolved from a simple histological marker to a protein of significant biological and clinical importance, with research establishing it as a member of the RBFOX family of RNA-binding proteins involved in alternative splicing regulation. Unlike RBFOX1 and RBFOX2, which are expressed in both neuronal and non-neuronal tissues, RBFOX3/NeuN expression is restricted to neurons in the central and peripheral nervous systems, making it uniquely important for neuronal gene expression regulation [@liu2012].

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RBFOX3/NeuN Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RBFOX3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RBFOX3/NeuN</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=RBFOX3" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Rbfox3 Neun Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

.infobox.infobox-protein [@liu2012]
!! RBFOX3 - RBFOX3/NeuN Protein [@chen2013]
| Protein Name | [RBFOX3](/proteins/rbfox3-protein) | [@chow2009]
| Gene | [RBFOX3](/proteins/rbfox3-protein) | [@hua2014]
| UniProt ID | [Q8WWI5](https://www.uniprot.org/uniprot/Q8WWI5) |
| Molecular Weight | 46.3 kDa |
| Subcellular Localization | Nucleus (neuronal) |
| Protein Family | RBFOX family |
| Domain Structure | N-terminal low-complexity region, RRM domain, C-terminal low-complexity region |
| Tissue Expression | Brain (neurons only), retina |
| Brain Regions | Cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, basal ganglia, spinal cord |
| Aliases | NeuN, Rbfox3, Hrbfox3A |

Overview

RBFOX3, most famously known as NeuN (Neuronal Nuclear Protein), is a neuron-specific RNA-binding protein that serves as one of the most widely used markers for identifying neurons in histological studies. Originally discovered as a nuclear antigen recognized by monoclonal antibodies, RBFOX3 has evolved from a simple histological marker to a protein of significant biological and clinical importance.

NeuN was first identified in 1992 when monoclonal antibodies raised against mouse brain tissue revealed a nuclear protein specifically expressed in post-mitotic neurons. For decades, NeuN has been the gold standard for neuronal identification in neuroanatomy, neurodevelopment, and neuropathology. However, its molecular function remained obscure until research established it as a member of the RBFOX family of RNA-binding proteins.

Unlike RBFOX1 and RBFOX2, which are expressed in both neuronal and non-neuronal tissues, RBFOX3/NeuN expression is restricted to neurons in the central and peripheral nervous systems, making it uniquely important for neuronal gene expression regulation.

Structure and Molecular Biology

Protein Domain Architecture

RBFOX3/NeuN contains the characteristic RBFOX family domain structure. The N-terminal low-complexity region contains glutamine-rich sequences implicated in transcriptional regulation and protein-protein interactions. The central RNA recognition motif (RRM), spanning approximately 90 amino acids, mediates sequence-specific RNA binding to the (U)GCAUG motif. The C-terminal low-complexity region functions in subcellular localization and protein interactions. The RBFOX3 RRM shares high homology with RBFOX1 and RBFOX2, suggesting similar RNA-binding specificity. However, RBFOX3 has distinct expression patterns and target genes due to neuron-specific regulatory mechanisms.

Subcellular Localization

NeuN exhibits neuron-specific nuclear localization. RBFOX3/NeuN is predominantly nuclear in mature neurons and is notably absent from nucleolar regions. Nuclear localization increases with neuronal maturation, making it a useful indicator of neuronal development stage.

Normal Biological Functions

Neuronal Differentiation Marker

RBFOX3/NeuN expression is a hallmark of neuronal differentiation. This protein is expressed exclusively in post-mitotic, differentiated neurons and appears late in neuronal development, after axon guidance and initial synapse formation. Importantly, RBFOX3/NeuN is continuously expressed in mature neurons throughout life, making it a reliable marker for neuronal maintenance and identity.

Alternative Splicing Regulation

As an RBFOX family member, RBFOX3/NeuN regulates alternative splicing of neuronal transcripts. It regulates splicing of transcripts involved in synaptic function, ion channel activity, and neuronal development. There is partial overlapping targeting with RBFOX1, suggesting functional redundancy between these family members. RBFOX3 specifically promotes the inclusion of neuron-specific exons in pre-mRNAs, contributing to the unique transcriptional landscape of neuronal cells.

Nuclear Organization

RBFOX3/NeuN may play roles in nuclear organization. It may influence chromatin structure in neurons and localizes to nuclear regions enriched for splicing machinery, potentially contributing to the formation of splicing factories within the neuronal nucleus.

Role in Neurodegenerative Diseases

Neurodegenerative Disease Context

While RBFOX3/NeuN is primarily studied as a marker, its dysfunction may contribute to neurodegeneration. Altered RBFOX3 activity may contribute to splicing defects observed in various neurodegenerative diseases [@kim2013]. As a neuron-specific protein, RBFOX3 may be involved in pathways selectively affecting neurons. Additionally, RBFOX3 splicing targets may overlap with TDP-43 (encoded by [TARDBP](/proteins/tardbp-protein)) targets, suggesting potential interactions between these proteins in disease contexts.

Neurodevelopmental Disorders

RBFOX3 mutations are linked to neurodevelopmental disorders. De novo mutations in RBFOX3 cause epileptic encephalopathy, while RBFOX3 haploinsufficiency is associated with intellectual disability. Furthermore, RBFOX3 is implicated in autism spectrum disorder (ASD) through genetic studies, highlighting its importance in normal neurodevelopment.

Diagnostic and Research Applications

Histological Marker

RBFOX3/NeuN is the most widely used neuronal marker in neurobiology. It is used to identify neurons in tissue sections, cell culture, and flow cytometry, making it essential for brain mapping and stereological counts of neuronal populations. In neuropathology, RBFOX3/NeuN is used to assess neuronal loss in disease states, and in developmental studies, it is used to track neuronal differentiation.

Limitations as a Marker

Important limitations should be considered when using RBFOX3/NeuN as a neuronal marker. Some neuronal populations, such as certain hypothalamic neurons and cerebellar Purkinje cells, do not express NeuN, making it not universal. Additionally, RBFOX3/NeuN is not expressed in early post-mitotic neurons, and expression patterns vary across species, requiring careful interpretation of experimental results.

Key Publications

See Also

• [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)))))))))))))
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [RNA Metabolism in Neurodegeneration](/rna-metabolism-in-neurodegeneration)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)
• [Alternative Splicing](/mechanisms/alternative-splicing-neurodegeneration)
• [RBFOX1 Protein](/proteins/rbfox1-protein)
• [RBFOX2 Protein](/proteins/rbfox2-protein)
• [RBFOX3 Gene](/proteins/rbfox3-protein)

External Links

• [UniProt: Q8WWI5](https://www.uniprot.org/uniprot/Q8WWI5)
• [Ensembl: ENSG00000169594](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000169594)
• [NCBI Gene: 65117](https://www.ncbi.nlm.nih.gov/gene/65117)

Background

The study of Rbfox3 Neun Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References